<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>chronic viral infections &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chronic-viral-infections/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 14 Jan 2026 16:51:47 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>chronic viral infections &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Harnessing CAR T-Cells for Chronic Viral Infections</title>
		<link>https://bioengineer.org/harnessing-car-t-cells-for-chronic-viral-infections/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jan 2026 16:51:23 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CAR-T cell therapy]]></category>
		<category><![CDATA[chronic viral infections]]></category>
		<category><![CDATA[immune evasion]]></category>
		<category><![CDATA[Immunotherapy advancements]]></category>
		<category><![CDATA[translational medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/harnessing-car-t-cells-for-chronic-viral-infections/</guid>

					<description><![CDATA[Chimeric Antigen Receptor T-Cell Therapy: A Revolutionary Approach to Chronic Viral Infections Chronic viral infections pose significant challenges to global health, affecting millions of individuals worldwide. Despite advancements in antiviral therapies, many patients experience persistent viral replication and chronic disease due to the virus’s ability to evade the immune system. In recent years, immunotherapy, and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316887</post-id>	</item>
	</channel>
</rss>
